[{"orgOrder":0,"company":"CicloMed","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Fosciclopirox","moa":"Cell membrane synthesis","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"CicloMed","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"CicloMed \/ Undisclosed","highestDevelopmentStatusID":"7","companyTruncated":"CicloMed \/ Undisclosed"},{"orgOrder":0,"company":"CicloMed","sponsor":"Cmed Clinical Services","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Fosciclopirox","moa":"Cell membrane synthesis","graph1":"Oncology","graph2":"Phase I","graph3":"CicloMed","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CicloMed \/ Cmed Clinical Services","highestDevelopmentStatusID":"6","companyTruncated":"CicloMed \/ Cmed Clinical Services"},{"orgOrder":0,"company":"CicloMed","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Cpx-Pom","moa":"Gamma secretase","graph1":"Oncology","graph2":"Phase II","graph3":"CicloMed","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CicloMed \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"CicloMed \/ Undisclosed"},{"orgOrder":0,"company":"CicloMed","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Cpx-Pom","moa":"Gamma secretase","graph1":"Oncology","graph2":"Phase I","graph3":"CicloMed","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CicloMed \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"CicloMed \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals by CicloMed

CicloMed
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check all FDF Dossiers for
this supplier

Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Contact Supplier

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

CicloMed

U.S.A

BIO Partnering at JPM

Not Confirmed

02

CicloMed

U.S.A

BIO Partnering at JPM

Not Confirmed

03

CicloMed

U.S.A

BIO Partnering at JPM

Not Confirmed

04

CicloMed

U.S.A

BIO Partnering at JPM

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.